27 March 2017
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics examines the immunogenicity of anti-TNF biologics and the role of patient, product and prescriber factors.
Anti-drug antibodies (ADAs) to biologic therapies contribute to the loss of response and infusion
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors